A day after the Reserve Financial institution of India appointed a further director on RBL Financial institution’s board and MD and CEO Vishwavir Ahuja went on “medical depart”, the financial institution claimed that these occasions are usually not a mirrored image of its monetary efficiency.
Rajeev Ahuja, government director of the financial institution who was appointed interim MD & CEO on Saturday, stated that the regulator’s resolution to nominate a director was largely to “strengthen the board.”
Whereas addressing reporters over a convention name on Sunday, Ahuja stated that the regulator had full religion within the financial institution’s administration and its monetary place.
“Financial institution and present administration crew have the complete assist of RBI. The developments are usually not in any method a mirrored image on our efficiency. We expect Q3 to be even higher than Q2 this yr, whereas This autumn would convey us again on monitor as we have been pre-Covid,” Ahuja informed reporters. “We’ve got absorbed all of the challenges on asset high quality.”
In line with Rajeev Ahuja, the method of discovering a successor for Vishwavir Ahuja had begun final yr, when the regulator solely gave a one yr extension to the previous MD and CEO. Vishwavir Ahuja’s time period was set to finish in June 2022.
“The board has elevated an present member of the administration crew to the MD & CEO function, which ought to allay any considerations on the power of the frranchise,” Rajeev Ahuja stated.
Whereas he has been recognized as a possible successor, his closing appointment as MD & CEO is topic to the RBI’s approval, Ahuja stated.